These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 15161657

  • 41. Identification of putative pathogenic microRNA and its downstream targets in anaplastic lymphoma kinase-negative anaplastic large cell lymphoma.
    Mehrotra M, Medeiros LJ, Luthra R, Sargent RL, Yao H, Barkoh BA, Singh R, Patel KP.
    Hum Pathol; 2014 Oct; 45(10):1995-2005. PubMed ID: 25128227
    [Abstract] [Full Text] [Related]

  • 42. The tyrosine phosphatase Shp2 interacts with NPM-ALK and regulates anaplastic lymphoma cell growth and migration.
    Voena C, Conte C, Ambrogio C, Boeri Erba E, Boccalatte F, Mohammed S, Jensen ON, Palestro G, Inghirami G, Chiarle R.
    Cancer Res; 2007 May 01; 67(9):4278-86. PubMed ID: 17483340
    [Abstract] [Full Text] [Related]

  • 43. Identification of a novel crosstalk between casein kinase 2α and NPM-ALK in ALK-positive anaplastic large cell lymphoma.
    Armanious H, Gelebart P, Anand M, Lai R.
    Cell Signal; 2013 Feb 01; 25(2):381-8. PubMed ID: 23153582
    [Abstract] [Full Text] [Related]

  • 44. Childhood anaplastic large cell lymphoma has a high incidence of ALK gene rearrangement as determined by immunohistochemical staining and fluorescent in situ hybridisation: a genetic and pathological correlation.
    Perkins SL, Pickering D, Lowe EJ, Zwick D, Abromowitch M, Davenport G, Cairo MS, Sanger WG.
    Br J Haematol; 2005 Dec 01; 131(5):624-7. PubMed ID: 16351638
    [Abstract] [Full Text] [Related]

  • 45. Proteomic analysis of anaplastic lymphoma cell lines: identification of potential tumour markers.
    Cussac D, Pichereaux C, Colomba A, Capilla F, Pont F, Gaits-Iacovoni F, Lamant L, Espinos E, Burlet-Schiltz O, Monsarrat B, Delsol G, Payrastre B.
    Proteomics; 2006 May 01; 6(10):3210-22. PubMed ID: 16596703
    [Abstract] [Full Text] [Related]

  • 46. Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK.
    Galkin AV, Melnick JS, Kim S, Hood TL, Li N, Li L, Xia G, Steensma R, Chopiuk G, Jiang J, Wan Y, Ding P, Liu Y, Sun F, Schultz PG, Gray NS, Warmuth M.
    Proc Natl Acad Sci U S A; 2007 Jan 02; 104(1):270-5. PubMed ID: 17185414
    [Abstract] [Full Text] [Related]

  • 47. High expression of Mcl-1 in ALK positive and negative anaplastic large cell lymphoma.
    Rust R, Harms G, Blokzijl T, Boot M, Diepstra A, Kluiver J, Visser L, Peh SC, Lim M, Kamps WA, Poppema S, van den Berg A.
    J Clin Pathol; 2005 May 02; 58(5):520-4. PubMed ID: 15858125
    [Abstract] [Full Text] [Related]

  • 48. IL-21 contributes to JAK3/STAT3 activation and promotes cell growth in ALK-positive anaplastic large cell lymphoma.
    Dien Bard J, Gelebart P, Anand M, Zak Z, Hegazy SA, Amin HM, Lai R.
    Am J Pathol; 2009 Aug 02; 175(2):825-34. PubMed ID: 19608866
    [Abstract] [Full Text] [Related]

  • 49. Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes.
    Piva R, Pellegrino E, Mattioli M, Agnelli L, Lombardi L, Boccalatte F, Costa G, Ruggeri BA, Cheng M, Chiarle R, Palestro G, Neri A, Inghirami G.
    J Clin Invest; 2006 Dec 02; 116(12):3171-82. PubMed ID: 17111047
    [Abstract] [Full Text] [Related]

  • 50. STAT1 is phosphorylated and downregulated by the oncogenic tyrosine kinase NPM-ALK in ALK-positive anaplastic large-cell lymphoma.
    Wu C, Molavi O, Zhang H, Gupta N, Alshareef A, Bone KM, Gopal K, Wu F, Lewis JT, Douglas DN, Kneteman NM, Lai R.
    Blood; 2015 Jul 16; 126(3):336-45. PubMed ID: 25921060
    [Abstract] [Full Text] [Related]

  • 51. Antitumor activity of pyridoisoquinoline derivatives F91873 and F91874, novel multikinase inhibitors with activity against the anaplastic lymphoma kinase.
    Kruczynski A, Mayer P, Marchand A, Vispé S, Fournier E, Annereau JP, Brel V, Barret JM, Delsol G, Imbert T, Fahy J, Bailly C.
    Anticancer Drugs; 2009 Jun 16; 20(5):364-72. PubMed ID: 19322071
    [Abstract] [Full Text] [Related]

  • 52. Expression of p27(Kip1) and c-Jun activation binding protein 1 are inversely correlated in systemic anaplastic large cell lymphoma.
    Rassidakis GZ, Claret FX, Lai R, Zhang Q, Sarris AH, McDonnell TJ, Medeiros LJ.
    Clin Cancer Res; 2003 Mar 16; 9(3):1121-8. PubMed ID: 12631617
    [Abstract] [Full Text] [Related]

  • 53. Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.
    Chen J, Zhang Y, Petrus MN, Xiao W, Nicolae A, Raffeld M, Pittaluga S, Bamford RN, Nakagawa M, Ouyang ST, Epstein AL, Kadin ME, Del Mistro A, Woessner R, Jaffe ES, Waldmann TA.
    Proc Natl Acad Sci U S A; 2017 Apr 11; 114(15):3975-3980. PubMed ID: 28356514
    [Abstract] [Full Text] [Related]

  • 54. Constitutive control of AKT1 gene expression by JUNB/CJUN in ALK+ anaplastic large-cell lymphoma: a novel crosstalk mechanism.
    Atsaves V, Zhang R, Ruder D, Pan Y, Leventaki V, Rassidakis GZ, Claret FX.
    Leukemia; 2015 Nov 11; 29(11):2162-72. PubMed ID: 25987255
    [Abstract] [Full Text] [Related]

  • 55. Apoptotic rate in peripheral T-cell lymphomas. A study using a tissue microarray with validation on full tissue sections.
    Rassidakis GZ, Jones D, Thomaides A, Sen F, Lai R, Cabanillas F, McDonnell TJ, Medeiros LJ.
    Am J Clin Pathol; 2002 Sep 11; 118(3):328-34. PubMed ID: 12219774
    [Abstract] [Full Text] [Related]

  • 56. Consequences of heat shock protein 72 (Hsp72) expression and activity on stress-induced apoptosis in CD30+ NPM-ALK+ anaplastic large-cell lymphomas.
    Bonvini P, Zorzi E, Mussolin L, Pillon M, Romualdi C, Peron M, d'Amore ES, Lamant L, Rosolen A.
    Leukemia; 2012 Jun 11; 26(6):1375-82. PubMed ID: 22289917
    [Abstract] [Full Text] [Related]

  • 57. Brefeldin A exerts differential effects on anaplastic lymphoma kinase positive anaplastic large cell lymphoma and classical Hodgkin lymphoma cell lines.
    Toda T, Watanabe M, Kawato J, Kadin ME, Higashihara M, Kunisada T, Umezawa K, Horie R.
    Br J Haematol; 2015 Sep 11; 170(6):837-46. PubMed ID: 26105086
    [Abstract] [Full Text] [Related]

  • 58. Anaplastic lymphoma kinase activity is essential for the proliferation and survival of anaplastic large-cell lymphoma cells.
    Wan W, Albom MS, Lu L, Quail MR, Becknell NC, Weinberg LR, Reddy DR, Holskin BP, Angeles TS, Underiner TL, Meyer SL, Hudkins RL, Dorsey BD, Ator MA, Ruggeri BA, Cheng M.
    Blood; 2006 Feb 15; 107(4):1617-23. PubMed ID: 16254137
    [Abstract] [Full Text] [Related]

  • 59. Matrix metalloproteinase-9 is upregulated in nucleophosmin-anaplastic lymphoma kinase-positive anaplastic lymphomas and activated at the cell surface by the chaperone heat shock protein 90 to promote cell invasion.
    Lagarrigue F, Dupuis-Coronas S, Ramel D, Delsol G, Tronchère H, Payrastre B, Gaits-Iacovoni F.
    Cancer Res; 2010 Sep 01; 70(17):6978-87. PubMed ID: 20699364
    [Abstract] [Full Text] [Related]

  • 60. p53 gene mutations are uncommon but p53 is commonly expressed in anaplastic large-cell lymphoma.
    Rassidakis GZ, Thomaides A, Wang S, Jiang Y, Fourtouna A, Lai R, Medeiros LJ.
    Leukemia; 2005 Sep 01; 19(9):1663-9. PubMed ID: 15990866
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.